ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
+5.53%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$284M
AUM Growth
+$284M
(-2%)
Cap. Flow
+$76.5M
Cap. Flow
% of AUM
26.96%
Top 10 Holdings %
Top 10 Hldgs %
67.52%
Holding
41
New
10
Increased
5
Reduced
16
Closed
5
Top Buys
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$22.9M |
| 2 |
Gilead Sciences
GILD
|
$16.1M |
| 3 |
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
|
$15.6M |
| 4 |
Sarepta Therapeutics
SRPT
|
$12.7M |
| 5 |
MDVN
MEDIVATION, INC.
MDVN
|
$12.4M |
Top Sells
| 1 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$12M |
| 2 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
$5.54M |
| 3 |
Vericel Corp
VCEL
|
$5.04M |
| 4 |
INNL
Innocoll Holdings plc Ordinary Shares
INNL
|
$4.16M |
| 5 |
DERM
Dermira, Inc.
DERM
|
$3.72M |
Sector Composition
| 1 | Healthcare | 81.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $30M | 10.48% | 1,404,055 +146,000 | +12% | +$3.12M |
|
2
Amicus Therapeutics
FOLD
$2.34B
| $28.9M | 10.09% | 3,424,104 -91,507 | -3% | -$773K |
|
|
3
BioMarin Pharmaceuticals
BMRN
$11.2B
| $22.9M | 7.98% | +277,272 | New | +$22.9M |
|
|
4
Sarepta Therapeutics
SRPT
$1.78B
| $22.5M | 7.87% | 1,155,000 +651,993 | +130% | +$12.7M |
|
|
5
Gilead Sciences
GILD
$140B
| $16.1M | 5.62% | +175,400 | New | +$16.1M |
|
6
Neurocrine Biosciences
NBIX
$13.8B
| $16M | 5.59% | 405,320 +278,320 | +219% | +$11M |
|
7
Iovance Biotherapeutics
IOVA
$807M
| $15.9M | 5.54% | 3,125,198 -62,409 | -2% | -$317K |
|
|
CPXX
8
DELISTED
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
| $15.6M | 5.45% | +1,416,257 | New | +$15.6M |
|
|
MDVN
9
DELISTED
MEDIVATION, INC.
MDVN
| $12.4M | 4.34% | +270,665 | New | +$12.4M |
|
10
Bristol-Myers Squibb
BMY
$96B
| $11.2M | 3.9% | +175,000 | New | +$11.2M |
|
|
AGEN
11
Agenus
AGEN
$133M
| $9.99M | 3.48% | 2,400,868 +201,731 | +9% | +$839K |
|
|
ANAC
12
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $8.91M | 3.11% | +166,700 | New | +$8.91M |
|
|
NDRM
13
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $7.59M | 2.65% | 537,477 +17,455 | +3% | +$246K |
|
14
Vanda Pharmaceuticals
VNDA
$279M
| $7.14M | 2.49% | 854,579 -406,230 | -32% | -$3.4M |
|
|
TSRO
15
DELISTED
TESARO, Inc.
TSRO
| $6.61M | 2.3% | +150,000 | New | +$6.61M |
|
|
SRNE
16
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $6.16M | 2.15% | 1,145,779 -800 | -0.1% | -$4.3K |
|
|
CASC
17
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $5.17M | 1.8% | 4,069,072 -50,000 | -1% | -$63.5K |
|
|
TLGT
18
DELISTED
Teligent, Inc
TLGT
| $4.53M | 1.58% | 925,000 -448,294 | -33% | -$2.2M |
|
|
LJPC
19
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $4.43M | 1.54% | 211,672 -572,527 | -73% | -$12M |
|
20
Fortress Biotech
FBIO
$76.8M
| $4.15M | 1.45% | 1,337,869 | – | – |
|
|
PTX
21
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $4.08M | 1.42% | 3,889,900 -1,255,016 | -24% | -$1.32M |
|
22
Veracyte
VCYT
$2.39B
| $3.95M | 1.38% | 730,514 -10,839 | -1% | -$58.5K |
|
|
DERM
23
DELISTED
Dermira, Inc.
DERM
| $3.62M | 1.26% | 175,000 -179,950 | -51% | -$3.72M |
|
|
GBT
24
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.3M | 1.15% | +208,086 | New | +$3.3M |
|
|
IMMU
25
DELISTED
Immunomedics Inc
IMMU
| $2.63M | 0.92% | +1,050,457 | New | +$2.63M |
|